iBio
IBIO
#10074
Rank
C$37.27 M
Marketcap
C$1.66
Share price
-6.25%
Change (1 day)
-54.35%
Change (1 year)

iBio (IBIO) - Net assets

Net assets on the balance sheet as of June 2025 : C$20.55 Million

According to iBio's latest financial reports the company has C$20.55 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

iBio - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$C$29.15 M43.22%
2023-06-30$C$20.35 M-75.09%
2022-06-30$C$81.72 M-39.26%
2021-06-30$C$0.13 B75.1%
2020-06-30$C$76.83 M2289.06%
2019-06-30$C$3.21 M-84.87%
2018-06-30$C$21.25 M83.53%
2017-06-30$C$11.58 M-62.83%
2016-06-30$C$31.15 M122.34%
2015-06-30$C$14.01 M115.31%
2014-06-30$C$6.5 M22.15%
2013-06-30$C$5.32 M-15.17%
2012-06-30$C$6.28 M3214.23%
2011-06-30$C$0.18 M-83.36%
2010-06-30$C$1.13 M-77.4%
2009-06-30$C$5.04 M-179.8%
2008-06-30$-C$6.32 Million37.55%
2007-06-30$-C$4.6 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Genocea Biosciences
GNCA
C$17.1 M-16.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.80 B 3,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$109.52 B 532,675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$0.11 B 471.81%๐Ÿ‡บ๐Ÿ‡ธ USA